Richard Nolan Townsend insider trades

Open-market stock purchases and sales by Richard Nolan Townsend, Chief Executive Officer at Lexeo Therapeutics, Inc, from SEC Form 4 filings since Jan 5, 2024.

Recent trades

DateStockTradeValue
Sep 24, 2026LXEO Lexeo Therapeutics, IncBought (not open market)—
Sep 14, 2026LXEO Lexeo Therapeutics, IncBought (not open market)$6.1K
Aug 18, 2026LXEO Lexeo Therapeutics, IncSold$16.6K
Jul 1, 2026LXEO Lexeo Therapeutics, IncSold$116K
Jun 29, 2026LXEO Lexeo Therapeutics, IncBought (not open market)—
May 18, 2026LXEO Lexeo Therapeutics, IncSold$16.9K
Apr 6, 2026LXEO Lexeo Therapeutics, IncSold$313K
Mar 13, 2026LXEO Lexeo Therapeutics, IncBought (not open market)$6.9K
Feb 18, 2026LXEO Lexeo Therapeutics, IncSold$64.9K
Feb 4, 2026LXEO Lexeo Therapeutics, IncBought (not open market)—
Feb 4, 2026LXEO Lexeo Therapeutics, IncBought (not open market)—
Nov 18, 2025LXEO Lexeo Therapeutics, IncSold$10.4K

Companies traded

  • LXEO Lexeo Therapeutics, Inc: 24 sales, last Sep 24, 2026

Get free alerts when Richard Nolan Townsend files a new trade →